Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000715812-19-000024
Filing Date
2019-09-13
Accepted
2019-09-13 11:04:55
Documents
43
Period of Report
2019-07-31

Document Format Files

Seq Description Document Type Size
1 bsyn20190731.htm 10-Q 174371
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER bsynx311.htm EX-31.1 9766
8 CERTIFICATION OF CHIEF ACCOUNTING OFFICER bsynx312.htm EX-31.2 9687
9 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED bsynx321.htm EX-32.1 5966
10 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION bsynx322.htm EX-32.2 5049
  Complete submission text file 0000715812-19-000024.txt   1213096

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE bsyn-20190701.xml EX-101.INS 145196
3 XBRL CALCULATION FILE bsyn-20190701_cal.xml EX-101.CAL 37318
4 XBRL DEFINITION FILE bsyn-20190701_def.xml EX-101.DEF 20134
5 XBRL LABEL FILE bsyn-20190701_lab.xml EX-101.LAB 116942
6 XBRL PRESENTATION FILE bsyn-20190701_pre.xml EX-101.PRE 89307
11 XBRL SCHEMA FILE bsyn-20190701.xsd EX-101.SCH 16289
Mailing Address 55 WEST MONROE STREET STE 1200 CHICAGO IL 60603
Business Address 55 WEST MONROE STREET STE 1200 CHICAGO IL 60603 8479560471
BIOSYNERGY INC (Filer) CIK: 0000715812 (see all company filings)

EIN.: 362880990 | State of Incorp.: IL | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-12459 | Film No.: 191091826
SIC: 3829 Measuring & Controlling Devices, NEC